2017
DOI: 10.3889/oamjms.2017.043
|View full text |Cite
|
Sign up to set email alerts
|

Expression of E-Cadherin/Beta-Catenin in Epithelial Carcinomas of the Thyroid Gland

Abstract: BACKGROUND:The aberrant activation of Wnt signalling pathway may be a common denominator for the development of thyroid tumorigenesis. It was announced that the loss of E-cadherin rather than β-catenin mutation represents a crucial event in determining the degree of differentiation of thyroid carcinomas.AIM:The aim of the study was to evaluate the expression of E-cadherin and β-catenin in the thyroid cancer tissue and to correlate these data with some histological and clinical parameters of the tumours.MATERIA… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

7
10
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 14 publications
(18 citation statements)
references
References 24 publications
7
10
1
Order By: Relevance
“…Our results thus confirm the efficacy of resveratrol to reverse RA resistance in ATC cells and suggest the potential clinical utility of this combination in the management of ATCs that are sensitive neither to resveratrol nor to RA. This notion is further supported by the redifferentiation tendency of resveratrol-treated THJ-11T in terms of increased Tg and E-cadherin production and, especially, the appearance of membranous E-cadherin localization that, as shown in the current study, are extremely low and even absent in undifferentiated and, especially, anaplastic thyroid cancers [ 26 , 27 , 28 , 29 ]. As the next step, the potential of resveratrol to improve I 131 uptake of ATC cells should be investigated.…”
Section: Discussionsupporting
confidence: 81%
“…Our results thus confirm the efficacy of resveratrol to reverse RA resistance in ATC cells and suggest the potential clinical utility of this combination in the management of ATCs that are sensitive neither to resveratrol nor to RA. This notion is further supported by the redifferentiation tendency of resveratrol-treated THJ-11T in terms of increased Tg and E-cadherin production and, especially, the appearance of membranous E-cadherin localization that, as shown in the current study, are extremely low and even absent in undifferentiated and, especially, anaplastic thyroid cancers [ 26 , 27 , 28 , 29 ]. As the next step, the potential of resveratrol to improve I 131 uptake of ATC cells should be investigated.…”
Section: Discussionsupporting
confidence: 81%
“…TGF-β induces the upregulation mesenchymal markers such as vimentin and downregulation of the epithelial marker E-cadherin, which are considered critical prerequisites for metastasis in numerous human cancers [72]. Therefore, it is not surprising that the expression of E-cadherin and β-catenin in thyroid cancer is associated with better prognosis [73]. Among the set of analyzed genes, TGFB1 was regulated differently in µg and in the presence of DEX.…”
Section: Cell Detachment In Microgravity and Epithelial-mesenchymal Tmentioning
confidence: 99%
“…As an important effector in the positive regulation of the Wnt signalling pathway, E-cadherin participates in signal transduction. 29 Downregulation of the protein expression of E-cadherin and upregulation of the expression of N-cadherin are distinguishing features of EMT, and these changes can enable tumour cells to acquire migration and invasion abilities. 30 Therefore, in this study, we explored the potential mechanism by which L. fermentum ZS09 inhibits the migration of colon cancer cells by blocking the EMT pathway.…”
Section: Discussionmentioning
confidence: 99%